| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |